Understanding the mechanisms of Kyn-induced apoptosis could reveal therapeutic opportunities, particularly in cancers where KP enzymes such as KMO are upregulated, and targeting Kyn accumulation might selectively induce apoptosis in tumor cells while not affecting normal tissues. Here, KMO is linked to cancer.